1-4 of 4
Jacqueline A. Dyck-Jones
Close
Sort by
Journal Articles

A Registry Study on Treatment of Patients with Acquired Protein C Deficiency with a Protein C Concentrate (Human)

Paul Knoebl, MD, Michael Sasse, MD, Maria Pia De Carolis, MD, Jacqueline A Dyck-Jones, PhD, Sandra Ehrle, MD, Maureen Finnerty, David Gelmont, MD, Leman Yel, MD, Mahmoud Loghman-Adham, MD, Doris Fischer, MD
Journal: Blood
Blood (2016) 128 (22): 3816.
https://doi.org/10.1182/blood.V128.22.3816.3816
Published: 2016
Journal Articles

Joint Bleeding Patterns in Patients Treated Prophylactically with an Extended Half-Life, Pegylated, Full-Length Recombinant Factor VIII (BAX 855)

Marilyn J. Manco-Johnson, MD, Alice D. Ma, MD, Robert Klamroth, Werner Engl, Lorena Griparic, PhD, Jacqueline A Dyck-Jones, PhD, Brigitt E. Abbuehl
Journal: Blood
Blood (2015) 126 (23): 2300.
https://doi.org/10.1182/blood.V126.23.2300.2300
Published: 2015
Journal Articles

Characteristics of Patients without Bleeding in a Pivotal Trial of Extended Half-Life, Pegylated, Full-length Recombinant Factor VIII (BAX 855) in the Treatment of Hemophilia A

Alice D. Ma, MD, Robert Klamroth, Marilyn J. Manco-Johnson, MD, Werner Engl, Jacqueline A Dyck-Jones, PhD, Brigitt E. Abbuehl
Journal: Blood
Blood (2015) 126 (23): 1105.
https://doi.org/10.1182/blood.V126.23.1105.1105
Published: 2015
Journal Articles

Safety and Efficacy Profile of rAHF-PFM for Immune Tolerance Induction as Assessed In 3 Clinical Trials (PUP ITI, PRE-PAIR, and PAIR).

Gerald Spotts, PhD, Brigitt E. Abbuehl, MD, Huong D. Luu, PharmD, Clara K. Song, PharmD, Jacqueline A. Dyck-Jones, Norma Guzman-Becerra, LieLing Wu, MyungShin Oh, Michael Zoerer, Judith Jill V. Sosa, Darby E. Stephens, Linda J. Yamamoto, MD, Bruce M. Ewenstein, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3670.
https://doi.org/10.1182/blood.V116.21.3670.3670
Published: 2010